What is Juvenile Myoclonic Epilepsy? Juvenile myoclonic epilepsy (JME) is an epileptic condition that develops in children and adolescents, invariably between the ages of 8 and 26 with most of the ...

Benign Adult Familial Myoclonic Epilepsy (BAFME) is an autosomal dominant disorder characterized by adult-onset cortical tremor or action myoclonus predominantly in the upper limbs, and generalized ...

A 25-year follow-up study reveals that 68% of patients with juvenile myoclonic epilepsy (JME) became seizure-free, with nearly 30% no longer needing antiepileptic drug (AED) treatment. A 25-year ...

The hospital pharmacies dominated the segment during forecast period. Doctors and hospital pharmacists are an essential component of the segment because pharmacists assist patients with the disease ...

A collaborative study describes a novel myoclonic epilepsy syndrome in dogs for the first time and discovers its genetic cause at DIRAS1 gene. The affected dogs developed myoclonic seizures at young ...

Jazz Pharmaceuticals Announces Initiation of Phase 3 Trial Evaluating Epidiolex®/Epidyolex® (cannabidiol) for Patients with Epilepsy with Myoclonic-Atonic Seizures ...

New findings about the treatment of the syndrome of feline audiogenic reflex seizures (FARS) have been provided by experts in a new article. FARS is a problem of older cats, which typically exhibit ...

A group of UK-based investigators from Davies Veterinary Group and the UCL School of Pharmacy, who recently engaged the veterinary world with an article defining the previously undocumented syndrome ...